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ABSTRACT Strains of the various Salmonella enterica serovars cause gastroenteritis
or typhoid fever in humans, with virulence depending on the action of two type III
secretion systems (Salmonella pathogenicity island 1 [SPI-1] and SPI-2). SptP is a Sal-
monella SPI-1 effector, involved in mediating recovery of the host cytoskeleton
postinfection. SptP requires a chaperone, SicP, for stability and secretion. SptP has
94% identity between S. enterica serovar Typhimurium and S. Typhi; direct compari-
son of the protein sequences revealed that S. Typhi SptP has numerous amino acid
changes within its chaperone-binding domain. Subsequent comparison of ΔsptP S.
Typhi and S. Typhimurium strains demonstrated that, unlike SptP in S. Typhimurium,
SptP in S. Typhi was not involved in invasion or cytoskeletal recovery postinfection.
Investigation of whether the observed amino acid changes within SptP of S. Typhi
affected its function revealed that S. Typhi SptP was unable to complement S. Typhi-
murium ΔsptP due to an absence of secretion. We further demonstrated that while
S. Typhimurium SptP is stable intracellularly within S. Typhi, S. Typhi SptP is unsta-
ble, although stability could be recovered following replacement of the chaperone-
binding domain with that of S. Typhimurium. Direct assessment of the strength of
the interaction between SptP and SicP of both serovars via bacterial two-hybrid
analysis demonstrated that S. Typhi SptP has a signiﬁcantly weaker interaction with
SicP than the equivalent proteins in S. Typhimurium. Taken together, our results
suggest that changes within the chaperone-binding domain of SptP in S. Typhi hin-
der binding to its chaperone, resulting in instability, preventing translocation, and
therefore restricting the intracellular activity of this effector.
IMPORTANCE Studies investigating Salmonella pathogenesis typically rely on Salmo-
nella Typhimurium, even though Salmonella Typhi causes the more severe disease in
humans. As such, an understanding of S. Typhi pathogenesis is lacking. Differences
within the type III secretion system effector SptP between typhoidal and nontyphoi-
dal serovars led us to characterize this effector within S. Typhi. Our results suggest
that SptP is not translocated from typhoidal serovars, even though the loss of sptP
results in virulence defects in S. Typhimurium. Although SptP is just one effector, our
results exemplify that the behavior of these serovars is signiﬁcantly different and
genes identiﬁed to be important for S. Typhimurium virulence may not translate to
S. Typhi.
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Salmonella species are diverse Gram-negative intracellular pathogens responsible fora range of diseases resulting in signiﬁcant morbidity and mortality among both
animals and humans worldwide (1). In humans, the outcome of infection with Salmo-
nella primarily depends on the infecting serovar; while nontyphoidal serovars, such as
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Salmonella enterica serovar Typhimurium, typically cause self-limiting gastroenteritis,
typhoidal serovars, such as Salmonella enterica serovar Typhi and Salmonella enterica
serovar Paratyphi, result in the invasive systemic disease typhoid fever (1).
Central to Salmonella virulence is the action of two type III secretion systems (T3SS),
encoded on Salmonella pathogenicity island 1 (SPI-1) and SPI-2, which secrete over 40
effectors to subvert host cell processes during infection (2–4). The SPI-1 T3SS is active
when Salmonella is extracellular, where it functions to permit the invasion of
nonphagocytic host cells (4), while the SPI-2 T3SS is activated upon internalization,
where it functions to create a stable and permissive intracellular niche, termed the
Salmonella-containing vacuole (SCV) (3, 4).
Although S. Typhi causes a more serious disease in humans, S. Typhimurium is often
used as the model for understanding Salmonella pathogenesis, owing to biosafety
concerns and, most importantly, the availability of viable in vivo models, since S. Typhi
and other typhoidal serovars are strictly restricted to humans (5). Despite the wide-
spread acceptance of S. Typhimurium as the Salmonella model organism, signiﬁcant
genomic differences exist between S. Typhimurium and S. Typhi. Comparison of S.
Typhimurium strain LT2 to S. Typhi reference strain CT18 revealed that 89% of genes
were shared; approximately 480 genes were unique to LT2 and approximately 600
genes were unique to CT18 (6). Signiﬁcant variations in prophage, pathogenicity island,
and plasmid elements were observed between the two serovars (6).
Importantly, many known SPI-1 and SPI-2 T3SS effectors are absent or pseudogenes
in S. Typhi, and this may be associated with genome degradation linked with host
restriction (6) and could contribute to the differences in pathogenicity observed
between typhoidal and nontyphoidal serovars. A notable example is the S. Typhimu-
rium effector GtgE, which is absent in S. Typhi (6); the introduction of GtgE into S. Typhi
permits its growth in nonpermissive mouse cells, strongly linking the absence of this
effector to typhoidal host restriction (7). Another example which highlights the limita-
tions of using S. Typhimurium to investigate Salmonella pathogenesis is the fact that
the Salmonella virulence plasmid (pSLT), encoding the effectors SpvB and SpvC, is
required for full S. Typhimurium virulence in mice (8) but absent in S. Typhi and other
typhoidal serovars (5, 9). Additional effectors that are either absent or pseudogenes in
S. Typhi (CT18) include SopA, CigR, SopE2, SlrP, SseJ, SopD2, AvrA, SteB, GogB, SseI/SrfH,
SseK1, SseK2, SseK3, and SspH1 (6, 10). Other effectors appear to be differentially
evolved between human-restricted and generalist serovars, including SipD, SseC, SseD,
SseF, SifA, and SptP (11), which could reﬂect functional differences. Further evidence of
the degradation of the T3SS effector repertoire has been reported within the highly
successful and globally dominant S. Typhi haplotype 58 (H58), which, owing to a
premature stop codon at position 185, lacks both the GTPase-activating phosphatase
(GAP) and tyrosine phosphatase domains of SptP and therefore lacks a functional copy
of this effector (12).
SptP is an SPI-1 effector encoded within the SPI-1 pathogenicity island immediately
downstream of its chaperone, SicP (13). Like other effectors, SptP requires its chaperone
for stability within the bacterial cytosol and to direct secretion (13, 14). SptP is a
modular protein consisting of three distinct domains: a chaperone-binding domain, a
GAP domain, and a tyrosine phosphatase domain. SptP is best characterized in its role
as a GTPase-activating protein, acting antagonistically to another SPI-1 effector, SopE/
SopE2, a guanine nucleotide exchange factor (GEF) which manipulates the host cyto-
skeleton to permit membrane rufﬂe formation and Salmonella internalization (2, 15).
SptP deactivates the Rho GTPases Rac1 and Cdc42 to reverse cytoskeletal changes and
return the host membrane to a steady-state condition (16). Importantly, extended
activation of Rho GTPases by SopE can be sensed by host cells by NOD1, resulting in
NF-B activation and proinﬂammatory signaling (17); antagonism of SopE by SptP
therefore represents an important mechanism to prevent the activation of host im-
mune defenses. SptP has also been reported to directly inhibit the activation of the
mitogen-activated protein kinase pathway and subsequently downregulate tumor
necrosis factor alpha secretion from infected J774A.1 macrophages (18). The less well
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characterized tyrosine phosphatase domain of SptP has been shown to be involved in
SCV biogenesis and bacterial replication up to 8 h postinfection (19). SptP is also
important for virulence in vivo, as a ΔsptP S. Typhimurium SL1344 strain demonstrates
attenuated virulence in BALB/c mice (20) and disruption of sptP in S. Typhimurium
ST4/74 also results in reduced intestinal colonization of chicks, pigs, and cattle (21).
Most of the characterization of SptP has been performed with S. Typhimurium (16,
22–24), with the underlying assumption being that S. Typhi behaves similarly. The
phenotypes attributed to SptP in S. Typhimurium, in particular, the virulence defects
reported during in vivo infection, would seemingly contradict the global success of H58
S. Typhi strains, which lack a functional copy of SptP (12). This suggests that the
function of this effector in S. Typhi may be different from that reported in S. Typhimu-
rium.
RESULTS
Comparison of SptP from different serovars. SptP is relatively conserved between
S. Typhimurium and S. Typhi, sharing 94% amino acid sequence identity between the
two serovars. Alignment of the amino acid sequences of SptP from S. Typhi Ty2 and
SptP from S. Typhimurium 14028 revealed that a large number of amino acid changes
(10/31) are concentrated within the chaperone-binding domain of SptP (residues 35 to
139 [25]) (Fig. 1A), despite SicP being highly conserved between serovars (97% identity).
Direct comparison of the chaperone-binding domains of SptP from various Salmonella
serovars shows that these amino acid changes are conserved between S. Typhi and S.
Paratyphi A and that these amino acids are distinct from those in nontyphoidal
serovars, including S. Typhimurium, S. Enteritidis, and S. Choleraesuis (Fig. 1B).
Further differences between sptP of S. Typhimurium and S. Typhi can be found
outside the protein-coding sequence. It has previously been demonstrated in S. Typhi-
murium that efﬁcient translation of SptP following transcription from its endogenous
locus depends on disruption of a stem-loop approximately 20 nucleotides upstream of
the start codon of SptP, which is mediated by the upstream translation of SicP (23).
Elongation of this stem-loop by just 3 nucleotides decreases the level of translation of
SptP by approximately 80% (23). Comparison of the predicted RNA structure (by use of
the Mfold server) (26) of this region between the two serovars reveals that S. Typhi
possesses an elongated stem-loop structure relative to the sequence of S. Typhimurium
(40 bp and 27 bp, respectively) (Fig. 1C), suggesting that the expression of SptP at the
level of translation may differ between the two serovars. Given these differences, we
investigated if SptP in S. Typhi has the same functions reported during S. Typhimurium
infection.
The role of SptP in Salmonella invasion and cytoskeletal recovery. In S. Typhi-
murium, the loss of sptP abolishes the ability of infected cells to recover the host
cytoskeleton, with cells displaying extended actin disruption up to 3 h postinfection;
conversely, cells infected with wild-type (WT) S. Typhimurium regain a normal cyto-
skeletal structure as soon as 80 min postinfection (16). To assess if the same phenotype
was seen during S. Typhi infection, we compared the ability of HeLa cells to regain a
normal actin cytoskeleton following infection with WT and ΔsptP S. Typhi strains. The
equivalent S. Typhimurium strains were used as controls.
During epithelial cell infection, both S. Typhimurium and S. Typhi manipulate the
host cytoskeleton, with membrane rufﬂes associated with invasion events clearly being
visible at 15 min postinfection (Fig. 2A). By 2 h, cells infected with WT Salmonella display
an actin architecture similar to that seen for uninfected cells, visible as the formation of
stress ﬁbers (Fig. 2A). In line with previous ﬁndings (16), cells infected with S. Typhi-
murium ΔsptP did not demonstrate cytoskeletal recovery and continued to exhibit
membrane rufﬂing and an absence of stress ﬁbers. In contrast, cells infected with S.
Typhi ΔsptP displayed a recovered cytoskeleton at 2 h postinfection. To quantify this
phenotype, we determined the proportion of infected cells displaying an actin archi-
tecture akin to that of uninfected cells at 2 h postinfection. While 76% of cells infected
with WT S. Typhimurium (n  309) demonstrated cytoskeletal recovery, only 27% of
SptP of Salmonella enterica Serovar Typhi Journal of Bacteriology
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cells infected with S. Typhimurium ΔsptP (n  315) demonstrated a recovered actin
cytoskeleton. In comparison, 70% of cells infected with either WT S. Typhi (n  294) or
S. Typhi ΔsptP (n  301) exhibited cytoskeletal recovery (Fig. 2B).
Although SptP has not previously been linked with invasion in S. Typhimurium (20,
27), SptP, via its antagonism of SopE, should directly govern the size and duration of
membrane rufﬂing and therefore inﬂuence the efﬁciency of invasion. As such, we
FIG 1 SptP of Salmonella Typhi. (A) Schematic of SptP showing amino acid changes (weakly similar or dissimilar amino
acids) between S. Typhimurium 14028 and S. Typhi Ty2. The location of the single nucleotide polymorphism (Q185*) which
generates a premature stop codon in H58 isolates is also shown. (B) Alignment of the sequence of the chaperone-binding
domain (positions 35 to 139) of SptP from various Salmonella serovars. Nonconserved amino acids are highlighted. (C)
Comparison of the mRNA structures upstream of the start codon of SptP present in S. Typhimurium and S. Typhi, predicted
by use of the Mfold server. Both the annotated ATG (AUG) start codon and the proposed TTG (UUG) start codon of SptP
are highlighted.
Johnson et al. Journal of Bacteriology
February 2017 Volume 199 Issue 4 e00647-16 jb.asm.org 4
 o
n
 February 12, 2018 by LO
NDO
N SCHO
O
L O
F HYG
IENE & TRO
PICAL M
EDICINE
http://jb.asm.org/
D
ow
nloaded from
 
FIG 2 Role of SptP in invasion and cytoskeletal recovery following exponential growth. Salmonella strains, grown
aerobically to late exponential phase, were used to infect HeLa cells at an MOI of 100. (A) Representative images
of HeLa cells infected with WT or ΔsptP S. Typhimurium or S. Typhi at 15 min and 2 h postinfection. Actin was
stained with phalloidin (white), bacteria were stained with the CSA-1 antibody (green), and nuclei were stained with
Hoechst (blue). Arrowheads, invasion-associated membrane rufﬂes (15 min) or stress ﬁbers (120 min). (B) HeLa cells
infected with Salmonella strains were ﬁxed at 2 h postinfection (PI) and stained with phalloidin to determine the
(Continued on next page)
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compared the levels of invasion of WT and ΔsptP S. Typhimurium and S. Typhi strains
into HeLa cells. While deletion of sptP from S. Typhimurium resulted in a signiﬁcantly
increased level of invasion relative to that of the WT strain, deletion of sptP from S.
Typhi did not affect the invasion efﬁciency (Fig. 2C). Increasing the length of time that
Salmonella was incubated with host cells improved the invasion efﬁciency of all strains
but did not alter the trends observed (Fig. 2C). SPI-1-deﬁcient S. Typhimurium (ΔprgH)
and S. Typhi (ΔinvA) strains, used as controls, failed to invade HeLa cells, as expected
(see Fig. S1 in the supplemental material).
Growth under different SPI-1-inducing conditions inﬂuences SopE activity in S.
Typhi. A recent study comparing S. Paratyphi A and S. Typhimurium following growth
under different SPI-1-inducing conditions demonstrated that S. Paratyphi was signiﬁ-
cantly less invasive, had reduced levels of SPI-1 expression, and had reduced levels of
SptP and SopE2 following aerobic growth to late exponential phase compared to the
results obtained by microaerobic growth to stationary phase (28). Since our initial
comparisons between WT and ΔsptP Salmonella strains were performed following
aerobic exponential growth (Fig. 2), we were interested in whether SopE, the guanine
exchange factor which SptP antagonizes (16), was active during S. Typhi infection after
growth under these conditions.
To determine if environmental conditions impact SopE activity, we assessed the
invasiveness of WT or ΔsopE S. Typhi and S. Typhimurium strains following aerobic
growth to late exponential phase or microaerobic growth to stationary phase. Since S.
Typhimurium 14028 expresses SopE2 but lacks SopE (29), while S. Typhi Ty2 expresses
SopE but not SopE2 (6, 30), we instead used the S. Typhimurium strain SL1344, which
has both SopE and SopE2 (31), for the comparisons in order to account for any
differences in activity or regulation between SopE and SopE2 (31). Following growth to
late exponential phase, deletion of sopE in S. Typhi resulted in a modest decrease in the
rate of invasion into HeLa cells, with a relative invasion rate of 84.4% of that of the WT
(Fig. 3A). When grown to stationary phase, however, invasion of the S. Typhi ΔsopE
strain was signiﬁcantly attenuated (0.002% invasion efﬁciency, with a relative invasion
rate of 0.5% of that of the WT) (Fig. 3A). A ΔinvA S. Typhi strain was unable to invade
HeLa cells following growth to either exponential phase or stationary phase, demon-
strating that invasion under both conditions is SPI-1 dependent (Fig. S1). In contrast, S.
Typhimurium SL1344 did not demonstrate this marked phenotypic difference between
growth conditions, as the ΔsopE (Fig. 3B) and ΔsopE ΔsopE2 (Fig. 3C) strains demon-
strated similar reductions in the rates of invasion following growth to either late
exponential or stationary phase.
Since these results suggest that SopE is nonessential for S. Typhi invasion following
aerobic subculture to late exponential phase, it follows that SptP would also be
dispensable, potentially explaining the lack of phenotypes previously observed for S.
Typhi ΔsptP compared to S. Typhimurium ΔsptP (Fig. 2). The role of SptP in invasion and
cytoskeletal recovery postinfection was therefore reassessed as before, but with strains
instead being grown under microaerobic conditions to stationary phase. While signif-
icant differences in invasion and cytoskeletal recovery were observed between the WT
and ΔsptP S. Typhimurium strains, no signiﬁcant differences between the WT and ΔsptP
S. Typhi strains were observed (Fig. 4).
Complementation of S. Typhimurium sptP with S. Typhi sptP. Since the loss of
SptP does not result in phenotypes during S. Typhi infection the same as those
observed during S. Typhimurium infection, it suggests that functional differences exist
FIG 2 Legend (Continued)
proportion of infected cells displaying a normal actin cytoskeleton. At least 100 infected cells were counted per
strain and per biological repeat. Error bars show SDs (n  3). The levels of cytoskeletal recovery of WT and ΔsptP
strains were compared by t test (***, P  0.001; n.s., no signiﬁcant difference). (C) HeLa cells were infected with WT
or ΔsptP S. Typhimurium 14028 or S. Typhi Ty2 for 15, 30, or 60 min. The percentage of intracellular bacteria at 2
h postinfection relative to the number of bacteria added in the inoculum is shown. Error bars show SDs (n  3).
The invasion rates of the strains were compared by t test (**, P  0.01; ***, P  0.001).
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between the SptP proteins from these serovars. SptP was one of several Salmonella
T3SS proteins identiﬁed as being differentially evolved between typhoidal and nonty-
phoidal serovars (11). We therefore investigated if expression of S. Typhi SptP would be
able to cross complement S. Typhimurium ΔsptP. As shown above (Fig. 2 and 4),
deletion of sptP from S. Typhimurium results in a signiﬁcant increase in the level of
invasion of HeLa cells. While complementation with S. Typhimurium sptP restored the
level of invasion back to WT levels, S. Typhimurium ΔsptP expressing sptP from S. Typhi
was as invasive as both the ΔsptP strain and the ΔsptP strain carrying the empty
pWSK29 vector (Fig. 5). Furthermore, a ΔsptP S. Typhimurium strain expressing the
truncated SptP present within H58 strains was as invasive as the strain expressing Ty2
SptP (Fig. 5).
The inability of S. Typhi SptP to complement S. Typhimurium ΔsptP could be due to
either the amino acid changes within the GAP and tyrosine phosphatase domains
FIG 3 Growth conditions alter the dependency on SopE for invasion in S. Typhi. Salmonella strains were
grown either aerobically to late exponential phase (subculture) or to stationary phase under microaero-
bic conditions (static overnight culture) and added to HeLa cells at an MOI of 100. Cells were infected for
1 h with WT and ΔsopE S. Typhi (A) and 15 min for WT, ΔsopE, and ΔsopE ΔsopE2 S. Typhimurium SL1344
(B and C). The percentage of intracellular bacteria at 2 h postinfection relative to the number of bacteria
added in the inoculum is shown. Error bars show SDs (n  3). The invasion rates of the strains were
compared by t test (*, P  0.05; **, P  0.01; ***, P  0.001; n.s., no signiﬁcant difference).
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FIG 4 Role of SptP in invasion and cytoskeletal recovery following growth to stationary phase. Salmonella strains,
grown under microaerobic conditions to stationary phase, were used to infect HeLa cells at an MOI of 100. (A)
Representative images of HeLa cells infected with WT or ΔsptP S. Typhimurium 14028 or S. Typhi Ty2 at 15 min and
2 h postinfection. Actin was stained with phalloidin (white), bacteria were stained with the CSA-1 antibody (green),
and nuclei were stained with Hoechst (blue). Arrowheads, invasion-associated membrane rufﬂes (15 min) or stress
ﬁbers (120 min). (B) HeLa cells infected with Salmonella strains were ﬁxed at 2 h postinfection and stained with
phalloidin to determine the proportion of infected cells displaying a normal actin cytoskeleton. At least 100
(Continued on next page)
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rendering it functionally inactive or the numerous substitutions within the chaperone-
binding region compromising the ability of S. Typhi SptP to bind the SicP chaperone,
therefore destabilizing SptP intracellularly and preventing its secretion by the SPI-1
T3SS (13, 14) (Fig. 1). We tested these two possibilities by performing an SPI-1 secretion
assay with hemagglutinin (HA)-tagged SptP expressed in S. Typhimurium. While SptP
from both S. Typhimurium and S. Typhi was detected intracellularly in WT S. Typhimu-
rium, S. Typhi SptP was observed at lower levels and only S. Typhimurium SptP was
detected in culture supernatants, with secretion being dependent on the presence of
a functional SPI-1 T3SS (Fig. 6). Similar levels of the SPI-1 translocon component SipD
were secreted by the WT strains, suggesting that the lack of S. Typhi SptP secretion
relates speciﬁcally to differences between the two SptP variants, likely from changes
within the chaperone-binding domain.
The chaperone-binding domain of SptP is essential for stability. Although SicP
is highly similar between S. Typhimurium and S. Typhi (97% identity), the inability of S.
Typhi SptP to function within S. Typhimurium might reﬂect its inability to efﬁciently
bind S. Typhimurium SicP, rather than indicating a general inability to bind its chap-
erone. As SicP binding of SptP also prevents the degradation of SptP within the
bacterial cytosol prior to secretion (13), the ability of SptP to bind SicP can be assessed
by detecting the total levels of HA-tagged S. Typhi and S. Typhimurium SptP in an S.
Typhi SPI-1 mutant background (ΔinvA), where secretion of effectors is prevented. Two
constructs were used to assess SptP stability for both S. Typhimurium and S. Typhi SptP:
one constitutively expressing SptP from the T3 promoter of pWSK29 and one express-
ing SptP from the endogenous promoter of each serovar, taken to be 700 bp upstream
from the SptP start codon, on the basis of the predicted transcriptional start site from
S. Typhimurium transcriptome sequencing data (32). While the T3 promoter accounts
for any regulatory differences between S. Typhi and S. Typhimurium, expression from
FIG 4 Legend (Continued)
infected cells were counted per strain and per biological repeat. Error bars show SDs (n  3). The levels of
cytoskeletal recovery of WT and ΔsptP strains were compared by t test (*, P  0.05; n.s., no signiﬁcant difference).
(C) HeLa cells were infected with WT or ΔsptP S. Typhimurium 14028 or S. Typhi Ty2 for 30 min. The percentage
of intracellular bacteria at 2 h postinfection relative to the number of bacteria added in the inoculum is shown.
Error bars show SDs (n  3). The invasion rates of the strains were compared by t test (***, P  0.001).
FIG 5 Expression of S. Typhi SptP fails to complement the deletion in S. Typhimurium. WT and ΔsptP S.
Typhimurium strains complemented with either empty pWSK29-Spec or plasmids expressing S. Typhi-
murium (Tm) or S. Typhi Ty2 SptP from a constitutive promoter were grown aerobically to late
exponential phase and added to HeLa cells at an MOI of 100. Strains were left to infect the cells for 15
min, and the number of intracellular bacteria was determined at 2 h postinfection. The percentage of
intracellular bacteria relative to the number of bacteria added in the inoculum is shown. Error bars show
SDs (n  3). The invasion rates of the strains were compared to the rate for the WT by one-way ANOVA,
followed by Tukey’s post hoc test (**, P  0.01; ***, P  0.001; n.s., no signiﬁcant difference).
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the endogenous promoter, which also encodes SicP, ensures the correct coregulation
of SicP and SptP at both the transcriptional and translational levels (23).
S. Typhi SptP-4HA was not detectable within bacteria following expression from
either the constitutive or endogenous promoter, while SptP-4HA from S. Typhimurium
was readily detectable following expression from either construct (Fig. 7). The stability
of S. Typhimurium SptP-4HA within S. Typhi indicates that SicP is still functional in this
serovar, suggesting that the instability of S. Typhi SptP results from changes within SptP
alone. It is worth highlighting that the doublet produced from the constitutive SptP-
4HA construct likely arises from forced expression from the current annotated ATG start
codon of SptP, as well as expression from a downstream TTG codon, reported to be the
true start site for SptP (23). Given that only the lower band was secreted (Fig. 6) and the
size of the S. Typhimurium product expressed by the endogenous promoter also
corresponds to that of the lower band, it is probable that the smaller band represents
the correct form of SptP.
In order to further conﬁrm that the instability of SptP in S. Typhi results from
changes within the chaperone-binding domain, constitutive HA-tagged SptP chimeras
were constructed in which the ﬁrst 139 residues of S. Typhimurium SptP were swapped
with those of S. Typhi and vice versa, and the proteins were again expressed in an S.
FIG 6 S. Typhimurium cannot secrete S. Typhi SptP. WT and SPI-1 mutant S. Typhimurium (ΔprgH) strains
expressing C-terminally 4HA-tagged SptP were grown to late exponential phase. The presence of S. Typhi
Ty2 or S. Typhimurium (Tm) SptP in bacterial pellets and the supernatant was detected using an anti-HA
antibody; the cytoplasmic protein DnaK was used to control for bacterial lysis, and the SPI-1 translocon
component SipD was used as a positive control for SPI-1 secretion. A representative blot of three
independent repeats is shown. The numbers on the left are molecular masses (in kilodaltons). Arrowhead,
the band which corresponds to SptP.
FIG 7 SptP is unstable within S. Typhi. SPI-1 mutant (ΔinvA) S. Typhi bacteria expressing S. Typhimurium
(Tm) or S. Typhi Ty2 SptP-4HA from either a constitutive T3 promoter or the endogenous promoter of
sptP were grown aerobically to late exponential phase. The presence of intracellular SptP was detected
using an anti-HA antibody. SipD was used as both a loading control and a positive control for SPI-1
expression. A representative blot of three independent repeats is shown. The numbers on the left are
molecular masses (in kilodaltons). Arrowhead, the band which corresponds to SptP; E.V., empty vector.
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Typhi SPI-1 null background (ΔinvA). As before, WT S. Typhi SptP was undetectable
within bacteria; however, when the SicP binding domain of S. Typhi SptP was replaced
with that of S. Typhimurium, S. Typhi SptP could be detected intracellularly (Fig. 8A). In
contrast, S. Typhimurium SptP was destabilized when given the S. Typhi SicP binding
domain, while the WT SptP remained readily detectable (Fig. 8A).
Since replacement of the chaperone-binding domain of SptP confers stability to S.
Typhi SptP, we were interested to see if these changes would also inﬂuence the activity
of S. Typhi SptP. Therefore, ΔsptP S. Typhimurium was transformed with both WT and
chimera S. Typhimurium and S. Typhi HA-tagged SptP, and invasion and cytoskeletal
recovery assays were performed. While expression of S. Typhimurium SptP-4HA de-
creased the level of invasion back to WT levels, a strain expressing S. Typhi SptP-4HA
was found to be as invasive as both the ΔsptP strain and the ΔsptP strain carrying the
empty pWSK29 vector (Fig. 8B), in line with our previous ﬁndings (Fig. 5). The same
pattern was observed with cytoskeletal recovery, with the S. Typhimurium SptP com-
plemented strain achieving recovery rates akin to those achieved with WT infection,
FIG 8 The chaperone-binding domain of S. Typhi SptP is responsible for its instability. (A) SPI-1 mutant
(ΔinvA) S. Typhi bacteria constitutively expressing either WT SptP-4HA from S. Typhimurium (Tm) or S.
Typhi Ty2 or SptP-4HA chimeras with the SicP binding domain switched with that of the other serovar
were grown aerobically to late exponential phase. The presence of SptP was determined using an
antibody against the HA tag. SipD was used as both a loading control and a positive control for SPI-1
expression. A representative blot of three independent repeats is shown. The numbers on the left are
molecular masses (in kilodaltons). Arrowhead, the band which corresponds to SptP. (B and C) HeLa cells
were infected with WT or ΔsptP S. Typhimurium strains constitutively expressing either WT SptP-4HA
from S. Typhimurium (Tm) and S. Typhi (Ty2) or the SptP-4HA chimeras for 15 min. The percentage of
intracellular bacteria at 2 h postinfection relative to the number of bacteria added in the inoculum is
shown (B), and the proportion of infected cells displaying normal actin cytoskeleton was enumerated (C).
At least 100 infected cells were counted per strain and per biological repeat. Error bars show SDs (n 
3). The invasion rates of the strains and cytoskeletal recovery were compared to those for the WT by
one-way ANOVA, followed by Tukey’s post hoc test (***, P  0.001; n.s., no signiﬁcant difference).
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while the strain expressing S. Typhi SptP demonstrated signiﬁcantly impaired cytoskel-
etal recovery at 2 h postinfection (Fig. 8C). However, ΔsptP S. Typhimurium expressing
the S. Typhimurium SptP chimera displayed signiﬁcantly increased invasion and signif-
icantly reduced cytoskeletal recovery compared to WT S. Typhimurium (Fig. 8), dem-
onstrating that the S. Typhi chaperone-binding domain abolishes the ability of S.
Typhimurium SptP to complement sptP deletion. Conversely, the ΔsptP S. Typhimurium
strain was fully complemented by expression of the S. Typhi SptP chimera, indicating
that the GAP domain of S. Typhi SptP is still functional.
Binding of SptP to SicP. Assessment of the secretion and stability of SptP within S.
Typhimurium and S. Typhi represents only an indirect way to measure SptP-SicP
binding. In order to directly determine the strength of the interaction between SptP
and SicP of both serovars, a bacterial two-hybrid assay was performed. SptP from S.
Typhimurium and S. Typhi was found to interact with SicP of both serovars, indicated
by the blue coloration of the colonies on Lennox broth (LB)–5-bromo-4-chloro-3-
indolyl--D-galactopyranoside (X-Gal) indicator plates arising from the reconstitution of
adenylate cyclase activity and subsequent induction of -galactosidase expression (33).
However, SptP-SicP interactions involving S. Typhi SptP resulted in a color change
weaker than that in the equivalent cotransformations involving S. Typhimurium SptP
(Fig. 9A). Since -galactosidase expression is correlated with the strength of the
interaction, a -galactosidase assay was performed on the resuspended colonies in
order to quantify the ability of SptP and SicP to interact between serovars. While S.
Typhimurium SptP could interact strongly with SicP from S. Typhimurium, the equiv-
alent interaction involving SptP and SicP from S. Typhi was signiﬁcantly weaker (Fig.
9B). Interestingly, the strength of the interaction between S. Typhimurium SptP and S.
Typhi SicP was equivalent to that of the interaction between S. Typhimurium SptP and
its endogenous chaperone (Fig. 9B), further validating that SicP in S. Typhi is still
functional.
Although replacement of the S. Typhimurium chaperone-binding domain with that
of S. Typhi does not signiﬁcantly decrease its interaction with SicP compared to that of
FIG 9 S. Typhi SptP interacts weakly with its chaperone, SicP. The interaction of SptP with its chaperone was assessed via
a bacterial two-hybrid assay. The adenylate cyclase T25 and T18 fragments were fused to the N terminus of SptP and SicP
of S. Typhimurium (Tm) and S. Typhi Ty2, respectively, and cotransformed into a cyaA mutant, E. coli DHM1. The levels of
coexpression of the T25 and T18 fragments alone (Empty) or fused to leucine zipper motifs (Zip) were used as negative
and positive controls, respectively. (A) Ten microliters of an overnight culture was spotted in triplicate on LB–X-Gal plates
and incubated at 30°C for 24 h. Blue colonies indicate restored adenylate cyclase activity. A representative plate is shown.
(B) Colonies were resuspended, and a -galactosidase assay was performed in order to quantify the strength of the
interaction between SptP and its chaperone, SicP (Miller units). Error bars show SDs (n  3). The levels of -galactosidase
expression induced by S. Typhimurium SptP and S. Typhi SptP were compared by t test (**, P  0.01).
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WT SptP, replacement of the chaperone-binding domain of S. Typhi SptP with that of
S. Typhimurium increased the ability of S. Typhi SptP to bind both S. Typhi and S.
Typhimurium SicP (Fig. 9B), reiterating that the reduced chaperone binding observed
within S. Typhi SptP likely arises through changes within its SicP binding domain.
DISCUSSION
The presence of a premature stop codon within the SPI-1 effector SptP in H58 strains
(12) led us to characterize the function of this effector during S. Typhi infection and
compare it to that of this effector during S. Typhimurium infection. To date, there has
been very limited characterization of SptP or, indeed, any Salmonella T3SS effector
using WT S. Typhi, with studies instead tending to use S. Typhimurium or attenuated S.
Typhi strains.
Our data demonstrate that SptP of S. Typhi has reduced chaperone binding,
resulting in intracellular instability and preventing secretion. Unsurprisingly, given the
instability of SptP within the Salmonella cytosol, deletion of sptP from S. Typhi Ty2 did
not affect the efﬁciency of invasion into HeLa cells, in line with the ﬁndings of a
previous study (24), and did not affect cytoskeletal recovery postinfection. Conversely,
S. Typhimurium SptP demonstrates strong binding to its chaperone, SicP, ensuring its
stability and secretion; as such, deletion of sptP from S. Typhimurium resulted in
signiﬁcant phenotypic differences, including increased invasion and a failure to recover
the host cytoskeleton postinfection, as previously reported (13, 16).
Although signiﬁcant differences between the ability of S. Typhimurium and S. Typhi
SptP to bind SicP were observed in our bacterial two-hybrid assay, this technique failed
to discern any signiﬁcant differences between the WT and chaperone-binding chimeras
of SptP, even though marked phenotypes with the SptP chimera constructs were seen
in Salmonella (Fig. 8). The use of Escherichia coli as a host, incubation at a lower
temperature (30°C), and overexpression of both SptP and SicP likely promoted protein-
protein interactions and reduced the overall sensitivity of the assay. However, experi-
ments conducted in both S. Typhimurium and S. Typhi demonstrate that changes
within the ﬁrst 139 amino acids of S. Typhi SptP, corresponding to the SicP binding
domain, are sufﬁcient to compromise its activity.
Our results strongly suggest that SptP is nonfunctional in S. Typhi. Interestingly, S.
Paratyphi A shares the same amino acid changes within the chaperone-binding do-
main, and SptP failed to be detected intracellularly by Western blotting from S.
Paratyphi A grown to late exponential phase (28), suggesting that the instability of SptP
may be a common feature of typhoidal serovars. This apparent loss of function may
explain how a premature stop codon within SptP within strains belonging to the
globally dominant S. Typhi H58 haplotype is tolerated (12), despite evidence from in
vivo S. Typhimurium infections demonstrating attenuated virulence when sptP is de-
leted (20, 21). This suggests that S. Typhimurium is not always an appropriate model for
typhoidal disease and that SptP, like the spv locus (8), may be required for systemic
disease in mice or other hosts but not humans.
Although pseudogenization or the loss of known SPI-1 and SPI-2 effectors within S.
Typhi has previously been reported (6, 10), the mechanism by which the function of
SptP has been lost—via multiple amino acid changes, reducing its interaction with its
chaperone—is unusual. A premature stop codon, such as that found in S. Typhi H58
strains (12), or even deletion of the gene would achieve the same end, without
expending the energy invested in the transcription or translation of SptP. This could
suggest that the loss of SptP function occurred gradually, maybe in conjunction with
the acquisition and assimilation of a new effector with a similar function that was better
suited to the induction of typhoidal disease; the presence of S. Typhi-speciﬁc effectors
is not unlikely, given that S. Typhi CT18 has almost 600 genes not found in S.
Typhimurium LT2 and effectors found only in S. Typhimurium and not S. Typhi are
common (6). Alternatively, SptP is relatively unique among SPI-1 effectors, in that it is
encoded within the SPI-1 pathogenicity island itself (4). Its central location within SPI-1
may not permit deletion or truncation without having deleterious effects on the
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transcription or translation of neighboring genes, such as hilA, thereby driving the loss
of function at the protein level.
If SptP is indeed not functional in S. Typhi, several key questions remain. Given that
extended Rho GTPase activation mediated by SopE during infection would lead to
proinﬂammatory signaling uncharacteristic of S. Typhi infection (17, 34), is another
effector responsible for antagonizing SopE in S. Typhi? Perhaps most intriguingly, the
question as to what function SicP, the chaperone of SptP, is performing in S. Typhi
remains. SicP is relatively conserved between serovars (97% identity); since S. Typhi-
murium SptP is stable within S. Typhi and is able to strongly interact with S. Typhi SicP
in a direct bacterial two-hybrid assay, we can be conﬁdent that SicP itself is still
functional in S. Typhi. It is currently thought that SicP acts as a chaperone for SptP only
(35); however, if it is not required to bind SptP in S. Typhi, it is unclear why its activity
has been preserved. Although SicP is better conserved between serovars than SptP,
there are amino acid changes. It is possible that, given time, these changes will
accumulate and decrease the activity of SicP. An alternative explanation could be that
SicP is simply acting as a chaperone for another, currently unknown effector.
Although the ﬁnding is not directly related to the function of SptP, we have also
observed that different environmental conditions induced S. Typhi-speciﬁc regulation
of the SPI-1 effector SopE. At present there are two accepted methods to induce SPI-1
expression, achieved either via aerobic growth to late exponential phase (subculture) or
through growth to stationary phase under microaerobic conditions (static overnight
culture) (28, 36). Our ﬁndings suggest that in comparison to S. Typhimurium, S. Typhi
has additional regulatory mechanisms to control SPI-1 activity, likely in response to
oxygen tension, acting at least at the level of SopE. Interestingly, a study comparing
global SPI-1 expression in S. Paratyphi A between the different SPI-1-inducing condi-
tions reported signiﬁcant differences in SPI-1 expression between aerobic and mi-
croaerobic growth (28), while a similar study using S. Typhimurium SL1344 did not (36).
Overall, this suggests that typhoidal serovars additionally use oxygen availability to
tightly control virulence gene expression, an observation that may help explain the
different diseases induced by typhoidal and nontyphoidal serovars.
Overall, this study demonstrates that the behavior of S. Typhi is signiﬁcantly
different from that of S. Typhimurium; the potential loss of function of SptP within S.
Typhi exempliﬁes just how different these serovars are, even at the level of a single
effector. This indicates that the ﬁndings of work performed in one serovar may not
directly translate to the other, highlighting the need for further studies to elucidate the
role of T3SS effectors in the context of S. Typhi infection.
MATERIALS AND METHODS
Bacterial strains, growth conditions, and cell culture. The strains and plasmids used in this study
are listed in Table 1. Salmonella strains were routinely grown in Lennox broth (LB; Sigma-Aldrich).
Kanamycin (50 g/ml), ampicillin (100 g/ml), and spectinomycin (100 g/ml) were supplemented as
required.
HeLa cells (ATCC) were maintained in Dulbecco’s modiﬁed Eagle medium (DMEM) supplemented
with 10% fetal bovine serum (FBS) (Sigma-Aldrich) in a 5% CO2 incubator at 37°C. Cells were maintained
at a maximum density of 1  106 cells/ml. The HeLa cells used in this study were authenticated via short
tandem repeat proﬁling in February 2016 (Microsynth).
Construction of plasmids and strains. A full list of the oligonucleotides used in this study can be
found in Table S1 in the supplemental material.
To permit the use of pWSK29 in ampicillin-resistant S. Typhi strains, pWSK29-Spec and pWSK29-
Spec-4HA were constructed by amplifying the backbone of pWSK29 (37) and pWSK29-4HA, without the
ampicillin resistance cassette, with primers containing NcoI and AvrII restriction sites (primer pair 1 and
2); the aadA gene, which confers resistance to spectinomycin, was ampliﬁed with primers containing the
same restriction sites (primer pair 3 and 4). In addition to digestion with NcoI and AvrII, both products
were digested with DpnI prior to ligation.
To create SptP complementation plasmids, SptP from S. Typhimurium 14028 (STM14_3477) and S.
Typhi Ty2 (t2780) and H58 were ampliﬁed with primers containing BamHI and KpnI restriction sites
(primer pair 5 and 6 and primer pair 7 and 8, respectively) and then cloned into these sites of
pWSK29-Spec, generating constructs which constitutively express untagged SptP.
To create HA-tagged SptP, pWSK29-Spec-4HA was ampliﬁed with a reverse primer containing the
PacI digestion site (primer pair 9 and 10). SptP was again ampliﬁed from both S. Typhimurium and S.
Typhi with primers containing BamHI and PacI restriction sites (primer pair 11 and 13 and primer pair 12 and
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13, respectively). Both products were digested, and SptP was cloned into the existing BamHI site and the
introduced PacI site of pWSK29-Spec-4HA, resulting in constitutively expressed C-terminally tagged SptP-4HA.
SptP-4HA expressed from its endogenous promoter was constructed in the sameway, with the exception that
SptP was ampliﬁed from both S. Typhimurium and S. Typhi with an additional 700 bp upstream from the
annotated start codon (primer pair 14 and 13) and ligated into pWSK29-Spec-4HA as described above.
To create SptP-4HA chimeras in which the chaperone-binding domain was switched with that of the
other serovar, the ﬁrst 417 bp of SptP, encompassing the SicP binding domain (amino acid positions 35
to 139), was ampliﬁed from the S. Typhimurium (primer pair 15 and 16) and S. Typhi (primer pair 17 and
18) chromosomes. The S. Typhimurium and S. Typhi/pWSK29-SptP-4HA plasmids were then ampliﬁed
without the SicP binding domain (primer pair 19 and 21 and primer pair 20 and 21, respectively), and the
two products (an S. Typhimurium/pWSK29-SptP-4HA backbone with S. Typhi SicP binding and vice versa)
were assembled via Gibson assembly (50°C, 30 min) (New England BioLabs).
To determine protein interactions by a bacterial two-hybrid assay, SptP (primer pair 22 and 24 and primer
pair 23 and 24 for S. Typhimurium and S. Typhi SptP, respectively) and SicP (primer pair 25 and 26 and primer
pair 25 and 27 for S. Typhimurium and S. Typhi SicP, respectively) were ampliﬁed from both S. Typhimurium
14028 and S. Typhi Ty2 and cloned into the BamHI and KpnI sites of pKT25 and pUT18C, generating SptP and
SicP fused to the C terminus of the T25 and T18 adenylate cyclase fragments.
Gene deletions were constructed via bacteriophage  red recombination as previously described
(38). Primers 28 and 30 were used to amplify the kanamycin resistance cassette of pKD4 with regions of
homology to S. Typhimurium sptP, and primer pair 29 and 30 was used to amplify the kanamycin
resistance cassette of pKD4 with regions of homology to S. Typhi sptP; primers 30 and 31 were used to
create a kanamycin resistance cassette with sopE ﬂanking regions; primer pair 32 and 33 was used to
create the sopE2 kanamycin resistance cassette product; and primers 41 and 42 were used to create the
kanamycin resistance cassette with regions of invA homology. Correct deletion of the gene via insertion
of the kanamycin resistance cassette was screened using primers 31 and 32 (sptP), 35 and 36 (sopE), 39
TABLE 1 Strains and plasmids used in this study
Strain or plasmid Identiﬁer Genotype or comments Source or reference
Strains
S. Typhimurium
14028 ICC797 WT This study
14028 ICC1373 ΔsptP::Kanr This study
14028 ICC796 ΔprgH::Tn5 This study
SL1344 ICC314 WT This study
SL1344 ICC1374 ΔsopE::Kanr This study
SL1344 ICC1376 ΔsopE::FRT ΔsopE2::Kanr This study
S. Typhi
Ty2 ICC1500 WT
Ty2 ICC1522 ΔsptP::Kanr This study
Ty2 ICC1556 ΔinvA::Kanr This study
Ty2 ICC1555 ΔsopE::Kanr This study
Plasmids
pWSK29-Amp 37
pWSK29-4HA This study
pWSK29-Spec pICC2489 Empty vector This study
pWSK29-Spec pICC2491 S. Typhimurium SptP, T3 promoter This study
pWSK29-Spec pICC2490 Ty2 SptP, T3 promoter This study
pWSK29-Spec pICC2535 H58 SptP, T3 promoter This study
pWSK29-Spec-4HA pICC2493 S. Typhimurium SptP-4HA, T3 promoter This study
pWSK29-Spec-4HA pICC2492 Ty2 SptP-4HA, T3 promoter This study
pWSK29-Spec-4HA pICC2494 S. Typhimurium SptP-4HA, endogenous promoter This study
pWSK29-Spec-4HA pICC2495 Ty2 SptP-4HA, endogenous promoter This study
pWSK29-Spec-4HA pICC2520 S. Typhimurium SptP-Ty2 SicP binding 4HA, T3 promoter This study
pWSK29-Spec-4HA pICC2521 Ty2 SptP-S. Typhimurium SicP binding 4HA, T3 promoter This study
pKT25 pICC2531 Empty vector Euromedex
pKT25 pICC2533 Zip Euromedex
pKT25 pICC2498 S. Typhimurium SptP This study
pKT25 pICC2499 Ty2 SptP This study
pUT18C pICC2532 Empty vector Euromedex
pUT18C pICC2534 Zip Euromedex
pUT18C pICC2504 S. Typhimurium SicP This study
pUT18C pICC2505 Ty2 SicP This study
pKD4 pICC893 Kanamycin resistance cassette template plasmid 38
pKD46 pICC1298 Bacteriophage lambda red recombinase plasmid 38
pCP20 pICC1303 FLP recombinase plasmid 38
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and 40 (sopE2), and 43 and 44 (invA). To create the SL1344 ΔsopE ΔsopE2 double mutant strain, the FLP
recognition target (FRT)-ﬂanked kanamycin resistance cassette within sopE was excised via FLP-mediated
recombination (pCP20), generating SL1344 sopE::FRT, prior to transformation with the sopE2 pKD4 PCR
product.
HeLa cell invasion assays. The invasiveness of the ΔsptP and ΔsopE strains relative to that of WT
Salmonella was determined by gentamicin protection assays. At 24 h prior to infection, HeLa cells were
seeded in a 24-well plate at a density of 7  104 cells/well. To induce expression of the SPI-1 T3SS,
Salmonella strains were either cultured overnight at 37°C and 200 rpm before they were subcultured 1:33
in LB until late exponential phase (optical density at 600 nm [OD600], 1.8) or cultured overnight at 37°C
without shaking. Salmonella was added to the cells at a multiplicity of infection (MOI) of 100:1, and the
cells and bacteria were incubated for 15 min for S. Typhimurium infections or for 30 min for infections
involving both S. Typhimurium and S. Typhi. The cells were then washed three times with phosphate-
buffered saline (PBS), before the addition of DMEM supplemented with 100 g/ml gentamicin. The cells
were further incubated for 1 h and washed with PBS, and the gentamicin concentration was reduced to
20 g/ml. At the required time points, the cells were again washed three times in PBS before the addition
of 0.1% Triton X-100. The cells were incubated for 5 min at room temperature (RT), before serial dilution
and plating onto LB agar plates to enumerate the intracellular bacteria.
Immunoﬂuorescence staining and microscopy. To compare the ability of the strains to recover the
host cytoskeleton postinfection, cells were seeded onto glass coverslips and infected as outlined above.
At the required time point, the cells were washed three times in PBS, before ﬁxation with 4%
paraformaldehyde for 15 min at room temperature, and were then washed a further three times in PBS.
The cells were then quenched in 50 mM ammonium chloride for 10 min at RT, prior to permeabilization
in 0.2% Triton X-100 for 4 min. Coverslips were blocked in 0.2% bovine serum albumin (BSA) for 5 min
before addition of the primary antibody diluted in 0.2% BSA for 1 h. Intracellular Salmonella bacteria were
detected using the CSA-1 antibody (1:200; Insight Biotechnology). The cells were again washed and
blocked, prior to addition of the appropriate secondary antibody (1:200 donkey anti-goat immunoglob-
ulin–Cy2; Jackson ImmunoResearch), Hoechst (1:1,000; Sigma), and phalloidin-tetramethyl rhodamine
isocyanate (1:100; Invitrogen) for 30 min at room temperature. The coverslips were washed in PBS before
they were mounted with ProLong Gold antifade reagent (Invitrogen) and visualized using a Zeiss Axio
Observer Z1 microscope at 100 magniﬁcation.
SPI-1 secretion assays and Western blotting. To determine the secretion of SptP, Salmonella
strains were grown aerobically to late exponential phase in 50 ml LB. The OD600 was recorded, and 1 ml
bacteria was pelleted and resuspended in 2 SDS loading buffer (1 M Tris, pH 6.8, 2% SDS, 20% glycerol,
5% -mercaptoethanol, bromophenol blue) in proportion to the OD600 reached to normalize bacterial
numbers (10 l of loading buffer per 0.1 OD600 unit). The remaining culture was centrifuged for 20 min
at 3,300  g before syringe ﬁltering (pore size, 0.2 m). Five milliliters of the cleared supernatant was
precipitated overnight at 4°C following the addition of 10% trichloroacetic acid (TCA). Precipitated
proteins were recovered by centrifugation at 20,000  g, followed by two acetone washes. The pellets
were left to air dry before the addition of 2 SDS loading buffer in the same volume used for the pellet
fractions. To determine SptP stability or intracellular protein levels, the strains were grown aerobically to
late exponential phase in 5 ml LB, before the OD600 was recorded and 1 ml was pelleted and resuspended
in 2 SDS loading buffer. Samples were then heated at 95°C for 10 min. Proteins were separated on 12%
acrylamide SDS-polyacrylamide gels, followed by semidry or wet transfer onto a polyvinylidene diﬂuoride
membrane (GE Healthcare). The membranes were blocked in 5% milk in PBS–0.05% Tween 20 and
blotted with either anti-DnaK 8E2/2 (1:10,000; Enzo Life Sciences), anti-HA (1:1,000; Sigma), or anti-SipD
(1:5,000) primary antibodies, followed by the addition of horseradish peroxidase-conjugated secondary
antibody (1:10,000; Jackson ImmunoResearch). Following the addition of the EZ-ECL reagent (Geneﬂow),
chemiluminescence was detected using a LAS-3000 imager (Fuji).
Bacterial two-hybrid and -galactosidase assays. E. coli DHM1 was cotransformed with pKT25 and
pUT18C constructs in various combinations, and transformants were selected on LB agar plates supple-
mented with kanamycin and ampicillin. Three colonies from each transformation were subsequently
grown overnight with antibiotic selection at 37°C. Ten microliters of these cultures was spotted onto LB
agar plates supplemented with kanamycin, ampicillin, 1 mM isopropyl--D-thiogalactopyranoside (IPTG),
and 0.1 mg/ml of 5-bromo-4-chloro-3-indolyl--D-galactopyranoside (X-Gal) and incubated at 30°C for 24
h. Colonies with reconstituted adenylate cyclase activity mediated by interaction of the fused proteins
were distinguished by their ability to metabolize X-Gal and subsequent blue coloration (33).
For quantitative analysis, colonies were resuspended in 1.2 ml LB. The OD600 was recorded, and the
bacteria were pelleted and resuspended in Z buffer (0.06 M Na2HPO4, 0.04 M NaH2PO4, 0.01 M KCl, 0.001
M MgSO4, 0.05 M -mercaptoethanol, pH 7). -Galactosidase assays were then performed as previously
described (39).
Statistical analysis. Statistical tests were performed using GraphPad Prism (version 7.00) software for
Windows (GraphPad Software, San Diego, CA, USA). All data are expressed as the mean  standard
deviation (SD). Signiﬁcance (P  0.05) was determined either by unpaired t test or by one-way analysis
of variance (ANOVA) followed by Tukey’s post hoc test.
SUPPLEMENTAL MATERIAL
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